These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 10571082

  • 1. The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains.
    Beard MB, O'Connell JC, Bolger GB, Houslay MD.
    FEBS Lett; 1999 Oct 22; 460(1):173-7. PubMed ID: 10571082
    [Abstract] [Full Text] [Related]

  • 2. The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).
    O'Connell JC, McCallum JF, McPhee I, Wakefield J, Houslay ES, Wishart W, Bolger G, Frame M, Houslay MD.
    Biochem J; 1996 Aug 15; 318 ( Pt 1)(Pt 1):255-61. PubMed ID: 8761480
    [Abstract] [Full Text] [Related]

  • 3. In addition to the SH3 binding region, multiple regions within the N-terminal noncatalytic portion of the cAMP-specific phosphodiesterase, PDE4A5, contribute to its intracellular targeting.
    Beard MB, Huston E, Campbell L, Gall I, McPhee I, Yarwood S, Scotland G, Houslay MD.
    Cell Signal; 2002 May 15; 14(5):453-65. PubMed ID: 11882390
    [Abstract] [Full Text] [Related]

  • 4. The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution.
    Huston E, Beard M, McCallum F, Pyne NJ, Vandenabeele P, Scotland G, Houslay MD.
    J Biol Chem; 2000 Sep 08; 275(36):28063-74. PubMed ID: 10829034
    [Abstract] [Full Text] [Related]

  • 5. Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition.
    McPhee I, Yarwood SJ, Scotland G, Huston E, Beard MB, Ross AH, Houslay ES, Houslay MD.
    J Biol Chem; 1999 Apr 23; 274(17):11796-810. PubMed ID: 10206997
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
    Saldou N, Obernolte R, Huber A, Baecker PA, Wilhelm R, Alvarez R, Li B, Xia L, Callan O, Su C, Jarnagin K, Shelton ER.
    Cell Signal; 1998 Jun 23; 10(6):427-40. PubMed ID: 9720765
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression, intracellular distribution and basis for lack of catalytic activity of the PDE4A7 isoform encoded by the human PDE4A cAMP-specific phosphodiesterase gene.
    Johnston LA, Erdogan S, Cheung YF, Sullivan M, Barber R, Lynch MJ, Baillie GS, Van Heeke G, Adams DR, Huston E, Houslay MD.
    Biochem J; 2004 Jun 01; 380(Pt 2):371-84. PubMed ID: 15025561
    [Abstract] [Full Text] [Related]

  • 10. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions.
    Beard MB, Olsen AE, Jones RE, Erdogan S, Houslay MD, Bolger GB.
    J Biol Chem; 2000 Apr 07; 275(14):10349-58. PubMed ID: 10744723
    [Abstract] [Full Text] [Related]

  • 11. TAPAS-1, a novel microdomain within the unique N-terminal region of the PDE4A1 cAMP-specific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid.
    Baillie GS, Huston E, Scotland G, Hodgkin M, Gall I, Peden AH, MacKenzie C, Houslay ES, Currie R, Pettitt TR, Walmsley AR, Wakelam MJ, Warwicker J, Houslay MD.
    J Biol Chem; 2002 Aug 02; 277(31):28298-309. PubMed ID: 11994273
    [Abstract] [Full Text] [Related]

  • 12. Intracellular compartmentalization of PDE4 cyclic AMP-specific phosphodiesterases.
    Scotland G, Beard M, Erdogan S, Huston E, McCallum F, MacKenzie SJ, Peden AH, Pooley L, Rena NG, Ross AH, Yarwood SJ, Houslay MD.
    Methods; 1998 Jan 02; 14(1):65-79. PubMed ID: 9500859
    [Abstract] [Full Text] [Related]

  • 13. Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3). Two N-terminal domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum.
    Shakur Y, Takeda K, Kenan Y, Yu ZX, Rena G, Brandt D, Houslay MD, Degerman E, Ferrans VJ, Manganiello VC.
    J Biol Chem; 2000 Dec 08; 275(49):38749-61. PubMed ID: 10952971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spectrin-anchored phosphodiesterase 4D4 restricts cAMP from disrupting microtubules and inducing endothelial cell gap formation.
    Creighton J, Zhu B, Alexeyev M, Stevens T.
    J Cell Sci; 2008 Jan 01; 121(Pt 1):110-9. PubMed ID: 18073242
    [Abstract] [Full Text] [Related]

  • 16. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M, Rohner D, Bichsel S.
    Biochem Biophys Res Commun; 1996 Mar 27; 220(3):729-34. PubMed ID: 8607833
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, Gilliland LK, Ledbetter JA, Tepper MA.
    Eur J Immunol; 1995 Oct 27; 25(10):2978-84. PubMed ID: 7589101
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene.
    Bolger GB, Erdogan S, Jones RE, Loughney K, Scotland G, Hoffmann R, Wilkinson I, Farrell C, Houslay MD.
    Biochem J; 1997 Dec 01; 328 ( Pt 2)(Pt 2):539-48. PubMed ID: 9371713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.